{
  "report_rows": [
    {
      "kpi": "Q2 Revenue",
      "prediction": "BEAT",
      "answer": "pred ~$5.35B vs. cons $5.21B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.05 vs. cons $1.92",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 Gross Margin",
      "prediction": "IN-LINE",
      "answer": "pred ~60.0% vs. cons 59.6%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Q3 Revenue Guide (midpoint)",
      "prediction": "BETTER",
      "answer": "guide ~$5.6B vs. cons ~$5.5B (Q3 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q3 EPS Guide (midpoint)",
      "prediction": "BETTER",
      "answer": "guide ~$2.10 vs. cons ~$2.06 (Q3 2026)",
      "confidence": "LOW"
    },
    {
      "kpi": "FY26 FCF/share framing",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8+/sh vs. cons ~$8/sh (FY2026)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -3.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": -5.0,
  "day5_path": "FADE",
  "day5_rationale": "Even on a Q2 beat and a modestly above-seasonal Q3 guide, the ~64% YTD run and premium multiple make 'sell-the-news' the base case: consensus already sits above the guide midpoint, so the beat is priced in and the burden falls on H2 durability. With management likely staying cautious on second-half breadth (2025 'false start' still fresh, auto/China soft) and depreciation/Silicon Labs charges capping GAAP EPS revisions, out-quarter estimates get only marginal upward revision \u2014 insufficient to support the valuation. Rich entry + muted revisions + soft-tone risk drive continued de-rating over the week.",
  "day5_confidence": "LOW"
}